Contract Research Opportunities

MC Diagnostics personnel have a wealth of experience in the design and development of molecular diagnostics applied to the fields of immunogenetics, blood banking and microbiology.

The assay platform currently under development will enable fully automated handling of any typing or screening, relying on the testing of a number of ligands.

The platform will be equally suited to both low and high throughput and will also deal equally with assays requiring between 2 and 225 individual signals.

We are happy to discuss the contract development of specific applications of our platform, with a view to licensing commercialisation, under strict confidentiality.

All development projects undertaken by MCD are subject to the requirements of ISO 9000, ISO 13485 and FDA QSR.

For further information, e-mail Peter Maguire.